Chief Operating Officer and Vice President, Business Development
Mr. Cano joined the company in 2018 with 20 years of corporate development experience in consultation, strategic planning, managing partnerships, and licensing expertise. Currently, he is the managing partner for consultation at C2 Strategic Solutions LLC, a company he founded, conducting business development and licensing for multiple life science and pharmaceutical companies. At C2, Mr. Cano oversees M&A, licensing, corporate growth, and strategic provision for organizations including Agile Therapeutics, Hitsamitsu, and Intec Pharma.
Prior to joining TFF Pharma, Mr. Cano held several upper business administration roles. While he was Vice President of Business Development at Aqua Pharmaceuticals, Chris managed corporate development strategy and business relationships. As Director of Business Development at Duchesnay USA, Inc., he was pivotal in the growth of the Women’s Healthcare Rx business in the US and Canada, and as Associate Director of Business Development at Noven Pharmaceuticals, he led the advancement of three separate business franchises.
In his position at TFF, Chris continues to focus on developing and managing revenue-generating opportunities and strategic partnerships with potential partners by identifying, evaluating, and executing licensing transactions for new development and commercialization opportunities.
Mr. Cano holds a Master of Business Management degree from Rider University and a Bachelor of Finance degree from Villanova University.